Skip To Main Content
Lucie Barbier on Muck Rack

Lucie Barbier

As seen in: MSN, MSN UK, Reuters, The Independent (UK), Wiley Online Library, Yahoo Canada, Yahoo News Australia, Yahoo News France, Yahoo News Malaysia, Yahoo Singapore and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Lucie

Contact Lucie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

UCB shares fall despite guidance upgrade as CEO flags higher H2 costs

|
By Lucie Barbier, Margaux Perrin
| MSN Verified
By Lucie Barbier and Margaux Perrin July 30 (Reuters) - Belgian biopharmaceutical group UCB raised its 2026 earnings guidance on Thursday, but its shares fell more than 8% as investors questioned whether some of the first-half earnings outperformance could be repeated in the second half. Adjusted EBITDA is now expected to grow in the mid-teens to low-twenties percentage range at constant exchange rates, up from a previous forecast of high single-digit to mid-teens growth.
Open in Who Shared Issue with article?

Philips falls 9% as weak orders, China concerns overshadow outlook hike

|
By Lucie Barbier, Alessandro Parodi Verified
| MSN UK Verified
; ; Continue reading More for You ; ; ; Continue reading More for You
Open in Who Shared View Duplicates (332) Issue with article?

Philips falls 9% as weak orders, China concerns overshadow outlook hike

|
By Lucie Barbier, Alessandro Parodi Verified
| Euronext
By Lucie Barbier and Alessandro Parodi July 28 (Reuters) - Philips shares fell 9% on Tuesday after the healthcare technology group reported weaker-than-expected orders and warned of a more challenging environment in China, overshadowing an improved full-year margin outlook. The Dutch maker of medical equipment and consumer health products on Monday raised its profitability guidance after reporting a second-quarter core profit margin above analysts' expectations, helped by U.S. tariff refunds.
Open in Who Shared View Duplicates (3) Issue with article?
See all 235 licensed articles (248 Total)